Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China · Delayed Price · Currency is CNY 11.55
+0.06 (0.52%)
Jun 9, 2026, 3:04 PM CST
SHE:300601 Market Cap
SHE:300601 has a market cap or net worth of 12.9 billion as of June 9, 2026. Its market cap has decreased by -17.73% in one year.
Market Cap
12.90B
Enterprise Value
12.95B
Revenue
2.66B
Ranking
n/a
PE Ratio
166.29
Stock Price
11.55
Market Cap Chart
Since February 7, 2017, SHE:300601's market cap has increased from 1.95B to 12.90B, an increase of 562.20%. That is a compound annual growth rate of 22.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 12.83B | -22.21% |
| Dec 31, 2025 | 16.50B | -13.88% |
| Dec 31, 2024 | 19.16B | -36.83% |
| Dec 29, 2023 | 30.32B | 11.35% |
| Dec 30, 2022 | 27.23B | -59.77% |
| Dec 31, 2021 | 67.70B | -43.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonghua Dongbao Pharmaceutical | 15.45B |
| Fujian Cosunter Pharmaceutical | 14.14B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.98B |
| Shenzhen Hepalink Pharmaceutical Group | 12.79B |
| Guobang Pharma | 12.44B |
| Henan Lingrui Pharmaceutical | 12.25B |
| Shanghai Shyndec Pharmaceutical | 12.02B |
| Beijing Aosaikang Pharmaceutical | 11.99B |